UMI-77
CAS No. 518303-20-3
UMI-77 ( UMI-77, UMI77, UMI 77 )
Catalog No. M14810 CAS No. 518303-20-3
A potent and selective Mcl-1 inhibitor with Ki of 0.49 uM; displays >10 fold selectivity against Bcl-w, Bfl-1, Bcl-xL and Bcl-2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 146 | In Stock |
|
5MG | 172 | In Stock |
|
10MG | 310 | In Stock |
|
25MG | 600 | In Stock |
|
50MG | 832 | In Stock |
|
100MG | 1165 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUMI-77
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective Mcl-1 inhibitor with Ki of 0.49 uM; displays >10 fold selectivity against Bcl-w, Bfl-1, Bcl-xL and Bcl-2.
-
DescriptionA potent and selective Mcl-1 inhibitor with Ki of 0.49 uM; displays >10 fold selectivity against Bcl-w, Bfl-1, Bcl-xL and Bcl-2; inhibits cell growth and induces apoptosis in pancreatic cancer cells; blocks the heterodimerization of Mcl-1/Bax and Mcl-1/Bak in cells; inhibits tumor growth in BxPC-3 xenograft model.
-
SynonymsUMI-77, UMI77, UMI 77
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorMcl-1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number518303-20-3
-
Formula Weight468.34
-
Molecular FormulaC18H14BrNO5S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 28 mg/mL
-
SMILESC1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br
-
Chemical NameAcetic acid, 2-[[4-[[(4-bromophenyl)sulfonyl]amino]-1-hydroxy-2-naphthalenyl]thio]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Abulwerdi F, et al. Mol Cancer Ther. 2014 Mar;13(3):565-75.
2. Mohammad RM, et al. Semin Cancer Biol. 2015 Dec;35 Suppl:S78-103.
3. Korfi K, et al. Cell Death Dis. 2016 Apr 7;7:e2177.
2. Mohammad RM, et al. Semin Cancer Biol. 2015 Dec;35 Suppl:S78-103.
3. Korfi K, et al. Cell Death Dis. 2016 Apr 7;7:e2177.
molnova catalog
related products
-
Maritoclax
Maritoclax (Marinopyrrole A) is a novel and specific Mcl-1 inhibitor.
-
Lisaftoclax
Bcl-2/Bcl-xl inhibitor 1 is a dual Bcl-2 and Bcl-xl inhibitor (IC50s: 2 nM and 5.9 nM for Bcl-2 and Bcl-xl) with anti-tumor activity. It is extracted from patent WO2018027097A1.
-
BI-3812
A highly potent and efficacious BCL6 inhibitor that potently inhibits the interaction of the BTB/POZ domain of BCL6 with several co-repressors in vitro with IC50 of <3 nM.